PP.08.25: SEVERITY OF LEFT VENTRICULAR REMODELLING IS ASSOCIATED WITH RENIN-MEDIATED ARTERIAL HYPERTENSION. (June 2015)
- Record Type:
- Journal Article
- Title:
- PP.08.25: SEVERITY OF LEFT VENTRICULAR REMODELLING IS ASSOCIATED WITH RENIN-MEDIATED ARTERIAL HYPERTENSION. (June 2015)
- Main Title:
- PP.08.25
- Authors:
- Kravtsova, O.
Kotovskaya, Y.
Dmitrova, T.
Khodorovich, N.
Safarova, A.
Kobalava, Z. - Abstract:
- Abstract : Objective: Plasma renin activity (PRA) measurement is an approach to guide antihypertensive treatment. RAAS blockers are effective in renin-mediated hypertension, whereas anti-volume drugs (e.g. diuretics or calcium channel blockers) - in low-renin hypertension. RAAS-blockers have proven their ability to regress left ventricular hypertrophy (LVH). The aim of study was to compare LV characteristics in subjects with low-renin and renin-mediated hypertension to confirm potential benefits of this treatment approach. Design and method: PRA (radioimmune assay) was measured in 72 hypertensive subjects (age 61, 1 ± 7, 6 years, 30 male). PRA < 0, 65 ng/ml/h was classified as volume (V)-type hypertension, PRA > 0, 65 ng/ml/h - as renin (R)-type. Echocardiographic parameters of LV remodelling and its function were compared in subjects with two types of hypertension. LVH criteria were: LV mass index (LVMI) > 125 g/m 2 in males and > 110 g/m 2 in females. p < 0, 05 was considered significant. Results: 42 (58%) subjects had V-type hypertension, 30 (42%) - R-type. Despite patients with V-type hypertension were older (respectively, 63, 1 ± 9, 1 vs 60, 3 ± 6, 4 years, p < 0, 05) and had higher systolic and diastolic BP (162, 6 ± 14, 1/103, 7 ± 11, 5 vs 157, 9 ± 17, 1/95, 0 ± 7, 8 mmHg), respectively, p < 0, 05). Patients with R-type hypertension vs those with V-type had significantly (p < 0, 05) larger left atrium diameter (3, 9 ± 0, 4 vs 3, 7 ± 0, 5 cm) and its volume index (39,Abstract : Objective: Plasma renin activity (PRA) measurement is an approach to guide antihypertensive treatment. RAAS blockers are effective in renin-mediated hypertension, whereas anti-volume drugs (e.g. diuretics or calcium channel blockers) - in low-renin hypertension. RAAS-blockers have proven their ability to regress left ventricular hypertrophy (LVH). The aim of study was to compare LV characteristics in subjects with low-renin and renin-mediated hypertension to confirm potential benefits of this treatment approach. Design and method: PRA (radioimmune assay) was measured in 72 hypertensive subjects (age 61, 1 ± 7, 6 years, 30 male). PRA < 0, 65 ng/ml/h was classified as volume (V)-type hypertension, PRA > 0, 65 ng/ml/h - as renin (R)-type. Echocardiographic parameters of LV remodelling and its function were compared in subjects with two types of hypertension. LVH criteria were: LV mass index (LVMI) > 125 g/m 2 in males and > 110 g/m 2 in females. p < 0, 05 was considered significant. Results: 42 (58%) subjects had V-type hypertension, 30 (42%) - R-type. Despite patients with V-type hypertension were older (respectively, 63, 1 ± 9, 1 vs 60, 3 ± 6, 4 years, p < 0, 05) and had higher systolic and diastolic BP (162, 6 ± 14, 1/103, 7 ± 11, 5 vs 157, 9 ± 17, 1/95, 0 ± 7, 8 mmHg), respectively, p < 0, 05). Patients with R-type hypertension vs those with V-type had significantly (p < 0, 05) larger left atrium diameter (3, 9 ± 0, 4 vs 3, 7 ± 0, 5 cm) and its volume index (39, 1 ± 7, 3 vs 36, 2 ± 7, 4 ml/m2), relative wall thickness (0, 63 ± 0, 12 vs 0, 57 ± 0, 11), LVMI (145, 9 ± 35, 6 vs 134, 3 ± 38, 4 g/m 2 ), deceleration time (256, 3 ± 55, 8 vs 179, 4 ± 40, 3 ms), E/È (12, 4 ± 5, 8 vs 10, 9 ± 4, 0) and LVH prevalence (93% vs 62%). Multivariate logistic analysis revealed independent association between PRA and LVMI (β=0, 78, p < 0, 001) and diastolic function characteristics E/A (β = −0, 49, p < 0, 001), isovolumic relaxation time (β = 0, 34, p < 0, 001), deceleration time (β = 0, 74, p < 0, 001), E/È (β=0, 68, p < 0, 001). Conclusions: Renin-mediated arterial hypertension is associated with adverse LV remodelling and diastolic dysfunction in hypertensive subjects. The finding confirms choice of RAAS-blockers as a beneficial therapeutic approach in those subjects to decrease BP and achieve LVH regression … (more)
- Is Part Of:
- Journal of hypertension. Volume 33(2015)Supplement 1
- Journal:
- Journal of hypertension
- Issue:
- Volume 33(2015)Supplement 1
- Issue Display:
- Volume 33, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 33
- Issue:
- 1
- Issue Sort Value:
- 2015-0033-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-06
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000467977.46253.7b ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7205.xml